Find trials
Search tips

A Study Of Chemotherapy Selection For PM For Colorectal And Appendiceal Cancers

Overview

About this study

The purpose of this study is to directly address PM, chemotherapy has been applied intra-peritoneally through a variety of methods, the most common being heated intra-peritoneal chemotherapy (HIPEC) at the time of cytoreduction surgery (CRS) for patients who qualify.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • All patients undergoing surgery for metastatic colorectal or appendiceal cancer for the peritoneum will be included. Subjects will need to have enough tumor burden during the procedure that extra tissue can be sent for research without compromising pathologic evaluation or increasing the risk of the surgery to resect additional tumor tissue.

Exclusion Criteria:

  • Subject not willing to provide consent.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 9/16/2025. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Sara Daniel

Contact us for the latest status

Contact information:

Cassandra Bell

(507) 422-9153

bell.cassandra@mayo.edu

More information

Publications

Publications are currently not available

More about research at Mayo Clinic

.
CLS-20596941

Mayo Clinic Footer